Top Markets
Coin of the day
Winston Medical Supply Co., Ltd. Winston Medical Supply Co., Ltd.

Winston Medical Supply Co., Ltd.

6817
Rangering i aksjer #28260
Winston Medical Supply Co., Ltd. is a firm dedicated to the creation,... Winston Medical Supply Co., Ltd. is a firm dedicated to the creation, production, and distribution of a wide array of pharmaceutical goods, dietary supplements, and beauty-enhancing health products. Its diverse inventory includes sterile ophthalmic formulations, such as gels, liquid suspensions, solutions, and emulsions for eye care. The company also manufactures hormonal medications, specifically contraceptives and oral suspensions designed for managing cancer-related cachexia. Additionally, its product range features topical applications, including various ointments. A significant portion of its offerings consists of diverse oral medications provided in various forms like powders, lozenges (troches), standard tablets, film-coated tablets, chewable forms, and capsules. These are developed to treat ailments such as common colds, digestive system issues, and other specific medical conditions. Established in 1974, Winston Medical Supply Co., Ltd. is based in Tainan City, Taiwan, and operates as a subsidiary of Medigen Biotechnology Corp.
Aksjekurs
$1.57
Markedsverdi
$28.87M
Endring (1 dag)
1.02%
Endring (1 år)
-55.19%
Land
TW
Handel Winston Medical Supply Co., Ltd. (6817)

Kategori

Inntekter for Winston Medical Supply Co., Ltd. (6817)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Winston Medical Supply Co., Ltd. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Winston Medical Supply Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter